Table 2.
Group | Number | |
1 | FC+ BMB+ BMA+ | 13/39 |
2 | FC− BMB− BMA− | 9/39 |
3 | FC+ BMB+ BMA− | 3/39 |
4 | FC− BMBu BMA− | 3/39 |
5 | FC− BMB+ BMA− | 2/39 |
6 | FC− BMB− BMAu | 2/39 |
7 | FC+ BMBu BMA− | 2/39 |
8 | FC+ BMB− BMA+ | 1/39 |
9 | FC− BMB+ BMA+ | 1/39 |
10 | FC− BMB+ BMAu | 1/39 |
11 | FCu BMB+ BMA− | 1/39 |
12 | FCu BMB− BMA− | 1/39 |
Total | 39 |
BMA, bone marrow aspirate; BMB, bone marrow trephine biopsy; FC, flow cytometry; NHL, non-Hodgkin’s lymphoma; +, positive for involvement by NHL; −, negative for involvement by NHL; u, uncertain for involvement by NHL.